| Product Specs |
Description |
| Manufacturer Name |
Octapharma |
| Indications |
FIBRYGA is indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia |
| Contraindications |
Anaphylactic or severe reactions to FIBRYGA or its components. |
| Viral Safety Process |
Solvent/detergent and nanofiltration |
| Product Half-Life |
75.9 ± 23.8 hours |
| Manufacturing Method |
Human-Derived Plasma |
| Storage Requirements/Shelf Life |
- Store at 2°C to 25°C (36°F to 77°F) for up to 30 months from date of manufacture.
- Do not freeze. Store in the original container to protect from light.
- After reconstitution, do not refrigerate or freeze.
- Use the reconstituted solution immediately or within 4 hours.
|
| Nominal Vial Size & Diluent Volume |
1 g/50 mL |
MANUFACTURER NAME LISTING
FACTOR TYPE LISTING
